Illicit drug use and liver transplantation: Is there a problem and what is the solution?

Transplant International

Volumn 21, Issue 10, 2008, Pages 923-929

  Webb, Kerry ^a   Shepherd, Liz ^b   Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Guidelines; Illicit drug use; Liver advisory group; Liver transplantation; Organ allocation

Indexed keywords

ALCOHOL; BUPRENORPHINE; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE; OPIATE;

ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ALCOHOLISM; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG ABUSE; DRUG DEPENDENCE; GRAFT RECIPIENT; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; LIFESTYLE; LIVER DISEASE; LIVER TRANSPLANTATION; MEDICAL EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TOBACCO DEPENDENCE; VIRUS HEPATITIS;

GREAT BRITAIN; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE ABUSE DETECTION;

EID: 51349164448     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00724.x     Document Type: Review

References (34)

1. Pageaux GP, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999 45 : 421.
2. Pageaux G, Perney P, Larrey D. Liver transplantation for alcoholic liver disease. Addict Biolog 2001 6 : 301.
3. National Institutes on Health Consensus. National Institute of Health Consensus Development Conference statement: liver transplantation. Hepatology 1984 3 : 107S.
4. Hoofnagle J, Kresina T, Fuller R, et al. Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland. Liver Transpl Surg 1997 3 : 347.
5. Neuberger J, Adams D, Mac Master P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. Br Med J 1998 317 : 172.
6. Dixon J, Welch HG. Priority setting: lessons from Oregon. Lancet 1991 337 : 891.
7. Moss A, Siegler M. Should alcoholics compete equally for liver transplantation? In : Kuhse H, Singer P, eds. Bioethics: An Anthology, 2nd edn. Oxford, UK : Blackwell Publishing, 2006.
8. Neuberger J, Price D. Role of living liver donation in the United Kingdom. Br Med J 2003 327 : 676.
9. Georgiou G, Webb K, Griggs K, Copello A. First report of a psychosocial intervention for patients with alcohol related liver disease undergoing liver transplantation. Liver Transpl 2003 9 : 772.
10. Webb K, Shepherd L, Day E, Masterton G, Neuberger J. Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl 2006 12 : 301.
11. Webb K, Neuberger J. Transplantation for alcoholic liver disease - transplants are appropriate for selected people with alcohol induced liver damage. Br Med J 2004 329 : 63.
12. McCallum S, Masterton G. Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria. Alcohol Alcohol 2006 41 : 358.
13. Burra P, Lucey M. Liver transplantation in alcoholic patients. Transpl Int 2005 18 : 491.
14. Bathgate A. Recommendations for alcohol-related liver disease. Lancet 2006 367 : 2045.
15. Dew M, DiMartini A, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008 14 : 159.
16. Department of Health. Hepatitis C Action Plan for England. London, UK : Department of Health, 2004.
17. Kanchana TP, Kaul V, Manzarbeitia C, et al. Liver transplantation for patients on methadone maintenance. Liver Transpl 2002 8 : 778.
18. Weinrieb RM, Barnett R, Lynch KG, De Piano M, Atanda A, Olthoff KM. A matched comparison study of medical and psychiatric complications and anaesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl 2004 10 : 97.
19. Department of Health. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London, UK : Department of Health, 2007.
20. Williams R. Doctors accused of refusing transplant on moral grounds. Br Med J 1997 314 : 1365.
21. Tome S, Sais A, Lucey M. Addictive behaviour after solid organ transplantation: what do we know already and what do we need to know? Liver Transpl 2008 14 : 127.
22. Hser YI, Anglin MD, Grella C, Longshore D, Prendergast M. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse Treat 1997 14 : 543.
23. Vaillant GE. What can long-term follow-up teach us about relapse and prevention of relapse in addiction? Br J Addict 1988 83 : 1147.
24. Koch M, Banys P. Liver transplantation and opioid dependence. J Am Med Assoc 2001 285 : 1056.
25. Best D, Day E, Morgan B. Addiction Careers and The Natural History of Change. London : National Treatment Agency for Substance Misuse, 2006.
26. Munoz S. Tobacco use by liver transplant recipients: Grappling with a smoking gun. Liver Transpl 2005 11 : 606.
27. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organised by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997 3 : 628.
28. Kreek MJ. Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis 1992 70 : 205.
29. NICE. Methadone and Buprenorphine for the Management of Opioid Dependence. NICE Technology Appraisal 114. London : National Institute for Health and Clinical Excellence, 2007.
30. Gossop M, Stewart D, Treacy S, Marsden J. NTORS at One Year. The National Treatment Outcome Research Study: Changes in Substance Use, Health and Criminal Behaviours One Year after Intake. London : Department of Health, 2002.
31. Nicholas Pugh R, White DG. Defining the Role of the Health Authority in the Assessment of Health Need and the Approach to Disease Control: Hepatitis C Among Injecting Drug Users. The Effective Management of Hepatitis C infection, 2nd edn. Cardiff, UK : Aesculapius Medical Press, 2003 : 135 pp.
32. Kandel D. Examining the gateway hypothesis: stages and pathways of drug involvement. In : Kandel D, ed. Stages and Pathways of Drug Involvement. Cambridge, UK : Cambridge University Press, 2002.
33. Dobbels F, Vanhaecke J, Nevens F, et al. Liver versus cardiothoracic transplant candidates and their pretransplant psychosocial and behavioural risk profiles: good neighbours or complete strangers? Transpl Int 2007 20 : 1020.
34. NICE. Drug Misuse: Psychosocial Interventions. NICE Clinical Guideline 51. London : National Institute for Health and Clinical Excellence, 2007.